Skip to content
healthcare.dev

Icatibant

NDC 55150-351, Icatibant, injection, solution, from Eugia US LLC.

Product NDC
55150-351
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213521
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-351 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ICATIBANT ACETATE30 mg/3mL

Pharmacologic classes

Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]

Package NDCNDC-11Package
55150-351-01551500351011 SYRINGE, GLASS in 1 CARTON (55150-351-01) / 3 mL in 1 SYRINGE, GLASS
55150-351-03551500351033 CARTON in 1 CARTON (55150-351-03) / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56d5047e-3f99-4100-af4f-388870986ced

Use it

Look up 55150-351 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-351 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.